WuXi Biologics (Cayman) I... (WXXWY)

PNK: WXXWY · Real-Time Price · USD

5.78

0.06 (1.05%)

At close: May 01, 2025, 3:59 PM

WuXi Biologics (Cayman) Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	17.12B	17.03B	16.55B	15.27B	13.09B	10.29B	8.08B	5.61B	4.32B	3.98B	3.09B	2.53B	2.02B	1.62B	1.23B	989.03M	688.65M
Cost of Revenue	10.5B	10.21B	9.68B	8.54B	7.14B	5.46B	4.03B	3.08B	2.55B	2.32B	1.81B	1.52B	1.21B	958.27M	766.19M	599.92M	411.66M
Gross Profit	6.62B	6.83B	6.87B	6.72B	5.95B	4.83B	4.05B	2.53B	1.77B	1.66B	1.27B	1.02B	811.01M	660.56M	466.75M	389.11M	276.99M
Operating Income	3.47B	3.95B	4.17B	4.35B	4.01B	3.17B	2.79B	1.5B	921.37M	947.97M	648.31M	522.38M	502.38M	410.69M	279.32M	225.9M	139.95M
Interest Income	64.67M	68.64M	25.73M	51.41M	43.08M	18.84M	36.58M	38.13M	31.79M	56.15M	93.83M	88.77M	29.85M	34.11M	46.31M	23.74M	7.96M
Pretax Income	3.65B	4.17B	4.96B	5.36B	4.87B	3.99B	3.32B	1.97B	1.32B	1.13B	964.69M	737.72M	472.57M	303.69M	194.27M	175.85M	130.47M
Net Income	2.63B	3.4B	4.15B	4.42B	4.08B	3.39B	2.79B	1.69B	1.3B	1.01B	831.06M	630.59M	410M	252.63M	149.44M	141.1M	106.11M
Selling & General & Admin	2.36B	2.09B	1.96B	1.69B	1.25B	1.13B	952.31M	721.96M	573.74M	451.09M	403.55M	326.1M	214.34M	175.39M	127.88M	109.93M	95.11M
Research & Development	795.2M	792.58M	759.88M	689.57M	663.58M	507.83M	299.93M	308.97M	276.25M	260.96M	222.19M	169.29M	94.29M	74.48M	59.55M	53.28M	50.01M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	763K
Operating Expenses	3.15B	2.65B	1.93B	1.42B	1.12B	854.61M	765.14M	605.34M	482.15M	588.22M	403.18M	368.81M	368.29M	329.93M	226.17M	189.52M	150.17M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.27M
Selling & Marketing Expenses	411.68M	294.01M	201.2M	162.91M	131.39M	124.65M	106.31M	94.42M	99.19M	77.08M	48.83M	42.43M	34.28M	27.62M	21.97M	15.33M	13.37M
Cost & Expenses	13.65B	12.86B	11.62B	9.96B	8.27B	6.32B	4.79B	3.68B	3.03B	2.91B	2.22B	1.89B	1.58B	1.29B	992.36M	789.44M	552.98M
Income Tax Expense	640.13M	603.18M	690.07M	807.87M	618M	484.54M	474.11M	324.26M	79.33M	116.3M	134.31M	107.26M	62.57M	51.06M	44.83M	34.75M	24.36M
Shares Outstanding (Basic)	2.15B	2.24B	2.18B	2.19B	2.19B	2.21B	2.19B	2.17B	2.04B	2.06B	1.99B	1.98B	1.97B	1.91B	1.54B	1.45B	1.45B
Shares Outstanding (Diluted)	2.13B	2.17B	2.17B	2.18B	2.19B	2.22B	2.2B	2.14B	2.07B	2B	1.99B	1.99B	1.95B	1.94B	1.54B	1.45B	1.45B
EPS (Basic)	1.20	1.54	1.90	2.02	1.86	1.54	1.28	0.80	0.64	0.50	0.42	0.32	0.22	0.14	0.10	0.10	0.08
EPS (Diluted)	1.22	1.56	1.90	2.02	1.86	1.54	1.28	0.80	0.64	0.50	0.42	0.32	0.22	0.14	0.10	0.10	0.08
EBITDA	4.74B	4.93B	4.83B	5.07B	4.6B	3.62B	3.16B	1.77B	1.16B	1.14B	875.16M	663.91M	605.73M	498.17M	373.8M	319.08M	213.57M
EBIT	3.45B	3.93B	4.17B	4.35B	4.01B	3.17B	2.79B	1.5B	921.37M	947.97M	648.31M	522.38M	502.38M	410.69M	279.32M	225.9M	143.98M
Depreciation & Amortization	1.29B	995.46M	659.82M	718.63M	585.58M	452.24M	367.9M	268.92M	235.6M	193.36M	226.85M	141.53M	103.35M	87.48M	94.47M	93.19M	42.01M